Perioperative Medicine Platform Trial (NCT07186634)
PROMPT O2
This trial is Currently recruiting
Registration number NCT07186634
Program & service
This trial is being run with the Surgery service, and as part of the Anaesthesia & Perioperative Medicine program.
Trial phase
Phase 4
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Prof Paul Myles
Key inclusion data
INCLUSION: Adult patient (≥18 years of age at time of admission); Scheduled to undergo a surgical procedure with a skin incision, expected duration of at least 2 hours, and a planned overnight hospital stay of at least 1 night (including, but not limited to, cardiac surgery, orthopaedic surgery, obstetric, or gynaecological surgery). EXCLUSION: ASA physical status 5 (moribund, not expected to survive with or without an operation); Previous participation in PROMPT within the previous 30 days. PROMPT O2 DOMAIN SPECIFIC EXCLUSION CRITERIA: ASA 1 or 2; Previous bleomycin therapy; current suspected or proven infection; Undergoing surgery for a cardiac or intra-thoracic procedure; Receiving (acute or long-term) oxygen therapy prior to surgery; The treating clinician considers that there is a specific indication for a specific oxygen regimen during the perioperative period; Not planned to receive mechanical ventilation during surgery.More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTRIf you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.